Tirzepatide
Tirzepatide/Glycine/B12 is an injectable medication that helps regulate blood sugar, reduce appetite, and lower inflammation. It works by activating two key receptors in the body, leading to better glucose control and weight loss.
ACTIVE INGREDIENTS
Tirzepatide
- GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist
Glycine
- An amino acid that helps to support muscle preservation throughout weight loss
Cyanocobalamin (Vitamin B12)
- Included for its potential role in easing nausea
HOW TO USE
Suggested Dosing
Injections should be administered subcutaneously (under the skin) one time weekly. Dosing typically begins at a lower dose, suggested initiation of 20 units (0.2 mL) weekly for the first 4 weeks, then escalates according to a titration schedule:
- Weeks 1–4: Inject 20 units (0.2 mL) one time per week
- Weeks 5–8: Inject 40 units (0.4 mL) one time per week
- Weeks 9–12: Inject 70 units (0.7 mL) one time per week
- Weeks 13–16: Inject 90 units (0.9 mL) one time per week
- Weeks 17–20: Inject 120 units (1.2 mL) one time per week
- Week 21+: Inject 140 units (1.4 mL) one time per week
Dosing may deviate from this pattern to accommodate patient-specific needs.
DISCLAIMER
This compounded medication is only available when the commercially available product is unavailable or when a prescriber determines that there is a clinically significant difference for the patient.
